Concepedia
Statistics
Publications
25
Citations
2.4K
H-Index
24
Active since
2003
Affiliations
National Cancer Institute(Current)
Science Applications International Corporation (United States)
Molecular Oncology (United States)
Moffitt Cancer Center
Frederick National Laboratory for Cancer Research
William Burgan is an author at National Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
2003–2022
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers
Suman Mukhopadhyay, Debanjan Goswami, Pavan P. Adiseshaiah et al. · Cancer Research · 2020 · 315 citations · Full text
Medicine, Cancer Biology, Oncology +17
Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275
Kevin Camphausen, William Burgan, Michael Cerra et al. · Cancer Research · 2004 · 211 citations
Medicine, Oncology, Pharmacology +16
Enhancement of <i>in vitro</i> and <i>in vivo</i> tumor cell radiosensitivity by valproic acid
Kevin Camphausen, David Cerna, Tamalee Scott et al. · International Journal of Cancer · 2004 · 191 citations · Full text
Medicine, Oncology, Pharmacology +17
<i>In vitro</i> and <i>In vivo</i> Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016
Andrea Russo, Hyuk‐Chan Kwon, William Burgan et al. · Clinical Cancer Research · 2009 · 166 citations · Full text
Medicine, Cancer Biology, Oncology +16
Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
Jeffery S. Russell, Kristin J. Brady, William Burgan et al. · PubMed · 2003 · 162 citations
Medicine, Oncology, Radiation Oncology +17
1–5 of 25